Showing 7051-7060 of 19322 results for "".
Breaking the Line: Moving Bispecific Antibodies Upstream in Treating Multiple Myeloma
https://reachmd.com/programs/cme/breaking-the-line-moving-bispecific-antibodies-upstream-in-treating-multiple-myeloma/49265/Learn how early-line bispecific antibodies are reshaping multiple myeloma treatment, supported by emerging efficacy and safety data from key clinical trials.What is the POSEIDON Classification?
https://reachmd.com/programs/global-womens-health-academy/what-is-the-poseidon-classification/9878/Dr. Humaidan discusses the POSEIDON classification and an overview of how it is utilized in clinical management.Differentiating Neuromodulation Therapies: VNS, DBS, ECT, TMS
https://reachmd.com/programs/cme/differentiating-neuromodulation-therapies-vns-dbs-ect-tms/35793/Tune in to learn about using vagus nerve stimulation (VNS) for the treatment of drug-resistant epilepsy (DRE) & treatment-resistant depression (TRD).Optimizing VNS Parameters: Keys to Therapeutic Success
https://reachmd.com/programs/cme/optimizing-vns-parameters-keys-to-therapeutic-success/35797/Tune in to learn about using vagus nerve stimulation (VNS) for the treatment of drug-resistant epilepsy (DRE) & treatment-resistant depression (TRD).Postpartum Depression: A Common Yet Overlooked Condition
https://reachmd.com/programs/medical-industry-feature/postpartum-depression-overlooked-condition/29760/Postpartum depression (PPD) symptoms are reported by about 13 percent, or roughly one in eight women, after giving birth.1 Despite being one of the most common medical conditions associated with pregnancy,2 women suffering from PPD often go undiagnosed.2,3 Tune in to hear Dr. Sarah Oreck and Dr. BroTitrating and Dosing Device Therapy for DRE: Best Practices for Optimizing Patient Outcomes
https://reachmd.com/programs/cme/titrating-and-dosing-device-therapy-for-dre-best-practices-for-optimizing-patient-outcomes/14854/How do you titrate & dose a patient on VNS therapy? Experts discuss best practices in adult & pediatric patients with add-on neuromodulation for DRE.Targeting the Fc Receptor Pathway to Treat Red Blood Cell Alloimmunization
https://reachmd.com/programs/cme/targeting-the-fc-receptor-pathway-to-treat-red-blood-cell-alloimmunization/13908/Delve deeper into the basic biology and functions of the FcRn receptor. Could it be the key to solving the clinical conundrum of HDFN?Optimizing the Role for Corticosteroids Within the Evolving DMD Treatment Landscape
https://reachmd.com/programs/cme/optimizing-the-role-for-corticosteroids-within-the-evolving-dmd-treatment-landscape/37232/Navigate corticosteroid use in DMD: Compare options, manage side effects, and align treatment with advanced therapies.VNS: Beyond Seizure Control
https://reachmd.com/programs/cme/vns-beyond-seizure-control/35795/Tune in to learn about using vagus nerve stimulation (VNS) for the treatment of drug-resistant epilepsy (DRE) & treatment-resistant depression (TRD).From Pathway to Patient: Clinical Advances in PI3K-Directed Therapy for HR+/HER2- mBC
https://reachmd.com/programs/cme/From-Pathway-to-Patient-Clinical-Advances-in-PI3K-Directed-Therapy-for-HR-HER2-mBC/35975/Join Drs. Jhaveri and Kalinsky and get up to speed on the latest data on PI3K-directed therapies and their role in the treatment paradigm for HR+, HER2- mBC.